{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:03:07Z","timestamp":1789952587708,"version":"4.0.1"},"reference-count":19,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:00:00Z","timestamp":1789862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmaceutical Statistics"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>In diagnostic accuracy studies, it is crucial to estimate the required sample size beforehand for the appropriate evaluation of diagnostic measures (e.g., sensitivity and\/or specificity). In the development of pharmaceuticals and medical devices, although frequentist approaches have been used for sample size determination, Bayesian approaches have gained attention recently. We propose a Bayesian method for sample size determination using two kinds of priors (i.e., analysis prior and design prior) based on \u201cBayesian power.\u201d In the proposed method, an analysis prior and a design prior were introduced for the sensitivity and\/or specificity parameters and a design prior for the prevalence parameter. For each possible future dataset at a given sample size, the analysis prior was updated to calculate the posterior probability of satisfying a prespecified success criterion. The design priors were used to obtain the prior predictive distribution of the future data, and Bayesian power was calculated as the prior predictive probability of satisfying the success criterion. Sample size determination was performed by evaluating Bayesian power over a range of candidate sample sizes according to a prespecified criterion. Numerical results showed that, under the parameter settings considered, the required sample size generally decreased as uncertainty in the design priors decreased when their means were above the corresponding target values. With the effective sample size of the analysis prior fixed, a more optimistic analysis prior reduced the required sample size. We also evaluated the method for joint sensitivity and specificity criteria and performed comparisons with commonly used frequentist methods. These results demonstrate how uncertainty represented by the design priors and information represented by the analysis prior affect Bayesian power and the required sample size.<\/jats:p>","DOI":"10.1002\/pst.70122","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:56:31Z","timestamp":1789952191000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bayesian Power\u2010Based Sample Size Determination for Diagnostic Accuracy Studies"],"prefix":"10.1002","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0280-5718","authenticated-orcid":false,"given":"Shunsuke","family":"Shiota","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science Kyoto Prefectural University of Medicine  Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6966-7215","authenticated-orcid":false,"given":"Go","family":"Horiguchi","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science Kyoto Prefectural University of Medicine  Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5243-3137","authenticated-orcid":false,"given":"Akari","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science Kyoto Prefectural University of Medicine  Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2401-0628","authenticated-orcid":false,"given":"Mitsuko","family":"Nakata","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science Kyoto Prefectural University of Medicine  Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-0597","authenticated-orcid":false,"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science Kyoto Prefectural University of Medicine  Kyoto Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,20]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","DOI":"10.1002\/9781118874905","volume-title":"Sample Sizes for Clinical Laboratory and Epidemiology Studies","author":"Machin D.","year":"2018"},{"key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s43441-022-00495-w","article-title":"Bayesian Statistics for Medical Devices: Progress Since 2010","volume":"57","author":"Campbell G.","year":"2023","journal-title":"Therapeutic Innovation and Regulatory Science"},{"key":"e_1_2_12_4_1","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/sim.9393","article-title":"Bayesian Sample Size Determination for Diagnostic Accuracy Studies","volume":"41","author":"Wilson K. J.","year":"2022","journal-title":"Statistics in Medicine"},{"key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41512-023-00153-1","article-title":"Sample Size Determination for Point\u2010Of\u2010Care COVID\u201019 Diagnostic Tests: A Bayesian Approach","volume":"7","author":"Williamson S. F.","year":"2023","journal-title":"Diagnostic and Prognostic Research"},{"key":"e_1_2_12_6_1","doi-asserted-by":"crossref","DOI":"10.1002\/pst.70087","article-title":"Bayesian Power\u2010Based Sample Size Determination for Single\u2010Arm Clinical Trials With Time\u2010To\u2010Event Endpoints","volume":"25","author":"Horiguchi G.","year":"2026","journal-title":"Pharmaceutical Statistics"},{"key":"e_1_2_12_7_1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/00031305.2021.1901782","article-title":"A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials","volume":"75","author":"Kunzmann K.","year":"2021","journal-title":"American Statistician"},{"key":"e_1_2_12_8_1","volume-title":"Bayesian Approaches to Clinical Trials and Health\u2010Care Evaluation","author":"Spiegelhalter D. J.","year":"2004"},{"key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40300-014-0043-2","article-title":"Bayesian\u2010Frequentist Sample Size Determination: A Game of Two Priors","volume":"72","author":"Brutti P.","year":"2014","journal-title":"Metron"},{"key":"e_1_2_12_10_1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/sim.3021","article-title":"A Bayesian Predictive Two\u2010Stage Design for Phase II Clinical Trials","volume":"27","author":"Sambucini V.","year":"2008","journal-title":"Statistics in Medicine"},{"key":"e_1_2_12_11_1","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1002\/sim.5505","article-title":"A Bayesian Predictive Sample Size Selection Design for Single\u2010Arm Exploratory Clinical Trials","volume":"31","author":"Teramukai S.","year":"2012","journal-title":"Statistics in Medicine"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1198\/016214505000000105","article-title":"Statistical Methods for Eliciting Probability Distributions","volume":"100","author":"Garthwaite P. H.","year":"2005","journal-title":"Journal of the American Statistical Association"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1214\/13-BA809","article-title":"On the Limiting Behavior of the Probability of Claiming Superiority in a Bayesian Context","volume":"8","author":"Eaton M. L.","year":"2013","journal-title":"Bayesian Analysis"},{"key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/00401706.1965.10490267","article-title":"The Use of Incomplete Beta Functions for Prior Distributions in Binomial Sampling","volume":"7","author":"Weiler H.","year":"1965","journal-title":"Technometrics"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-92298-0","volume-title":"Bayesian Computation With R","author":"Albert J.","year":"2009"},{"key":"e_1_2_12_16_1","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1002\/sim.1836","article-title":"On Sample Size for Sensitivity and Specificity in Prospective Diagnostic Accuracy Studies","volume":"23","author":"Li J.","year":"2004","journal-title":"Statistics in Medicine"},{"key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12885-021-08138-3","article-title":"PIVKA\u2010II Serves as a Potential Biomarker That Complements AFP for the Diagnosis of Hepatocellular Carcinoma","volume":"21","author":"Feng H.","year":"2021","journal-title":"BMC Cancer"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<769::AID-SIM495>3.0.CO;2-V","article-title":"Bayesian and Mixed Bayesian\/Likelihood Criteria for Sample Size Determination","volume":"16","author":"Joseph L.","year":"1997","journal-title":"Statistics in Medicine"},{"key":"e_1_2_12_19_1","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.1002\/sim.9871","article-title":"Bayesian Design and Analysis of Two\u2010Arm Cluster Randomized Trials Using Assurance","volume":"42","author":"Wilson K. J.","year":"2023","journal-title":"Statistics in Medicine"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.cct.2007.11.005","article-title":"Bayesian Design and Conduct of Phase II Single\u2010Arm Clinical Trials With Binary Outcomes: A Tutorial","volume":"29","author":"Zohar S.","year":"2008","journal-title":"Contemporary Clinical Trials"}],"container-title":["Pharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pst.70122","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pst.70122","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pst.70122","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:56:34Z","timestamp":1789952194000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pst.70122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,20]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1002\/pst.70122"],"URL":"https:\/\/doi.org\/10.1002\/pst.70122","archive":["Portico"],"relation":{},"ISSN":["1539-1604","1539-1612"],"issn-type":[{"value":"1539-1604","type":"print"},{"value":"1539-1612","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,20]]},"assertion":[{"value":"2026-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70122"}}